Aileron Therapeutics is a biopharmaceutical company that develops a class of drugs called Stapled Peptides.
Aileron Therapeutics is a biopharmaceutical company that develops a class of drugs called Stapled Peptides. Stapled Peptides represent the first general solution for modulating intracellular protein-protein interactions that are critical control points to nearly all functions of a cell.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 6, 2021 | Post-IPO Secondary | $35.90M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
|
— | Post-IPO Secondary |